CBFB and cancer: We next investigated the applicability of our results to human cancer by comparing our DEG analyses in mouse MC38 and E0771 cancer cells to a published RNA-seq dataset from wildtype and CBFβ deficient human breast cancer cells (MCF10A) [8].